A multi-country, Observational, cross-sectional study to characterise advanced Parkinson’s Disease patients in Movement Disorder Centres.

Not Applicable

Completed

• Conditions: Parkinson’s Disease; Neurological - Parkinson's disease

• Registration Number: ACTRN12615000477527
• Lead Sponsor: AbbVie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2500

Inclusion Criteria

Consecutive Parkinson’s Disease patients attending a routine visit at a participating clinic and who fulfil the following selection criteria can be included:
-adult male or female
-diagnosis of Parkinson’s Disease
-willingness to sign and date a Patient Authorization Form to use and disclose personal health information (or informed consent form if required)
-being able to speak the language of the provided patient questionnaire.

Exclusion Criteria

-Patients in the ‘off’ stage at the time of the visit
-Participation in a concurrent clinical study
-Significant uncertainty around the diagnosis of Parkinson’s Disease

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of Parkinson’s Disease patients identified as Advanced Parkinson’s Disease according to physician judgment<br>[Cross-sectional study, single routine visit<br>]